ArticleInternational journal of cancer2024
Recent trends in cervical cancer incidence, stage at diagnosis, and mortality according to county-level income in the United States, 2000-2019.
Article in International journal of cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.
- Self-collected vaginal specimens for human papillomavirus testing and guidance on screening exit: An update to the American Cancer Society cervical cancer screening guideline.CA: a cancer journal for cliniciansGuideline
- Trial
- Building capacity for equitable cervical cancer screening and follow-up in an FQHC-NCI cancer center partnership: a mixed-methods study of multilevel implementation determinants.BMC primary care · 2026Article
- Plasma proteomic biomarkers for predicting chemoradiation response in locally advanced cervical cancer.BMC women's health · 2026Article
- Disparities in HPV/PAP Testing Among U.S. Women: A Cross-Sectional Analysis of Healthcare Access, Internet Use, and Sociodemographic Factors.Health science reports · 2026Article
- Geographic clusters of human papillomavirus-associated cancer incidence in the US, 2008-2022.Preventive medicine · 2026Article
- The cervical cancer divide: state variation in incidence, mortality, and progress toward elimination in the United States.JNCI cancer spectrum · 2026Article
- Cancer prevalence in the United States: trends and sociodemographic disparities based on national health interview survey data (2019-2023).Frontiers in oncology · 2026Article
- From HPV genotypes to cervical lesion burden: public health-relevant heterogeneity across 1.29 million screening records in Guangdong, China.Frontiers in public health · 2026Article
- Declining trends but persistent disparities in cervical cancer mortality in the United States, 1999-2023.Frontiers in public health · 2026Article
- Development and Evaluation of Innovation Scales for Mail-Based Human Papillomavirus (HPV) Self-Collection Among U.S. Low-Income Women.Nursing reports (Pavia, Italy) · 2025Article
- Misconceptions and knowledge gaps about HPV, cervical cancer, and HPV vaccination among central American immigrant parents in the United States.Human vaccines & immunotherapeutics · 2025Article
- Socioeconomic Inequities in Pap Test Use Among Black Women in the United States: An Intersectional Approach.Journal of racial and ethnic health disparities · 2025Article
- A Pilot Study: Adaptation Phase of the PROMIS Women Education Program-Promoting Cervical Cancer Prevention Methods Among Muslim Women in Virginia.Cancer medicine · 2025Article
- Community-level Social Vulnerability and Cervical Cancer Mortality Among Young and Old Adults in the State of Alabama.Journal of community health · 2025Article
- National Outcomes of Increasing Cervical Cancer Screening in Federally Qualified Health Centers.JAMA network open · 2025Article
- Embracing and implementing the WHO cervical cancer elimination campaign goals: A consensus statement by SGO, ACOG, ASCCP, ASTRO, and ABS on minimum quality care standards for cervical cancer patients in the U.S.Gynecologic oncology · 2025Article
- County-Level Cervical Cancer Screening Coverage and Differences in Incidence and Mortality.JAMA network open · 2025Article
- Prophylactic vaccines against HPV-caused cervical cancer: novel vaccines are still demanded.Infectious agents and cancer · 2025Review
- Cost-Effectiveness of Pembrolizumab With Chemoradiotherapy for Locally Advanced Cervical Cancer.JAMA network open · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 1 country.
Funding
Abstract
Early evidence suggests that declining cervical cancer incidence reversed in low-income regions in the United States in recent years; however, it is unclear whether there are distinct patterns by race/ethnicity and stage at diagnosis and if the increase has translated into rising mortality. Using Surveillance, Epidemiology, and End Results data, we evaluated trends in hysterectomy-corrected cervical cancer incidence rates (2000-2019) and mortality rates (2005-2019) by county-level income and race/ethnicity, with further stratification of incidence by stage at diagnosis. Following a period of decline, hysterectomy-corrected cervical cancer incidence increased 1.0%/year (95% CI = 0.1% to 4.5%) among Non-Hispanic White women in low-income counties. Particularly, a statistically significant 4.4%/year (95% CI = 1.7% to 7.5%) increase in distant-stage cancer occurred in this group. Additionally, recent increases in cervical cancer mortality (1.1%/year [95% CI = -1.4% to 3.7%]) were observed among this group and Non-Hispanic Black women in low-income counties (2.9%/year [95% CI = -2.3% to 18.2%]), but trends were not statistically significant. Among Hispanic women in low-income counties, distant-stage cervical cancer incidence increased 1.5%/year (95% CI = -0.6% to 4.1%), albeit not statistically significant. The increasing incidence of distant-stage cervical cancer and mortality in specific racial/ethnic groups suggests that the recent introduction of higher sensitivity screening tests may not explain increasing trends in low-income counties. Our findings suggest that the observed rise in cervical cancer incidence may reflect disruptions along the screening and treatment continuum. Future research to further comprehend these trends and continued enhancements in prevention are crucial to combat rising cervical cancer incidence and mortality in low-income counties in the United States.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.